Impact of NRAS Mutations on the Diagnosis of Follicular Neoplasm of the Thyroid

Background. Most patients with a preoperative diagnosis of thyroid follicular neoplasm (FN) undergo diagnostic surgery to determine whether the nodule is benign or malignant. Point mutations at NRAS codon 61 are the most common mutations observed in FN. However, the clinical significance of NRAS mut...

Full description

Saved in:
Bibliographic Details
Main Authors: Ja-Seong Bae, Seung Kyu Choi, Sora Jeon, Yourha Kim, Sohee Lee, Youn Soo Lee, Chan Kwon Jung
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:International Journal of Endocrinology
Online Access:http://dx.doi.org/10.1155/2014/289834
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832559829362671616
author Ja-Seong Bae
Seung Kyu Choi
Sora Jeon
Yourha Kim
Sohee Lee
Youn Soo Lee
Chan Kwon Jung
author_facet Ja-Seong Bae
Seung Kyu Choi
Sora Jeon
Yourha Kim
Sohee Lee
Youn Soo Lee
Chan Kwon Jung
author_sort Ja-Seong Bae
collection DOAJ
description Background. Most patients with a preoperative diagnosis of thyroid follicular neoplasm (FN) undergo diagnostic surgery to determine whether the nodule is benign or malignant. Point mutations at NRAS codon 61 are the most common mutations observed in FN. However, the clinical significance of NRAS mutation remains unclear. Methods. From 2012 to 2013, 123 consecutive patients undergoing thyroidectomy for FN were evaluated prospectively. Molecular analyses for NRAS codon 61 were performed with pyrosequencing. Results. The overall malignancy rate in FN was 48.8% (60/123). Of 123 FNs, 33 (26.8%) were positive for the NRAS mutation. The sensitivity, specificity, positive predictive value, and negative predictive value of a NRAS mutation-positive FN specimen to predict malignancy were 37%, 83%, 67%, and 58%, respectively. Patients with a NRAS-positive FN had a higher malignancy rate in additional thyroid nodules beyond the FN than patients with a NRAS-negative FN. The overall malignancy rate of patients with a NRAS-positive FN was significantly higher than that of patients with a NRAS-negative FN (79% versus 52%; P = 0.008). Conclusions. Determining NRAS mutation status in FN helps to improve the accuracy of thyroid cancer diagnosis and to predict cancer risk in accompanying thyroid nodules.
format Article
id doaj-art-54c6e5a018164f8f9d48fb1ca07f6353
institution Kabale University
issn 1687-8337
1687-8345
language English
publishDate 2014-01-01
publisher Wiley
record_format Article
series International Journal of Endocrinology
spelling doaj-art-54c6e5a018164f8f9d48fb1ca07f63532025-02-03T01:29:10ZengWileyInternational Journal of Endocrinology1687-83371687-83452014-01-01201410.1155/2014/289834289834Impact of NRAS Mutations on the Diagnosis of Follicular Neoplasm of the ThyroidJa-Seong Bae0Seung Kyu Choi1Sora Jeon2Yourha Kim3Sohee Lee4Youn Soo Lee5Chan Kwon Jung6Department of Surgery, College of Medicine, The Catholic University of Korea, Seoul 137-701, Republic of KoreaDepartment of Hospital Pathology, College of Medicine, The Catholic University of Korea, 222 Banpodaero, Seocho-gu, Seoul 137-701, Republic of KoreaDepartment of Hospital Pathology, College of Medicine, The Catholic University of Korea, 222 Banpodaero, Seocho-gu, Seoul 137-701, Republic of KoreaDepartment of Hospital Pathology, College of Medicine, The Catholic University of Korea, 222 Banpodaero, Seocho-gu, Seoul 137-701, Republic of KoreaDepartment of Surgery, College of Medicine, The Catholic University of Korea, Seoul 137-701, Republic of KoreaDepartment of Hospital Pathology, College of Medicine, The Catholic University of Korea, 222 Banpodaero, Seocho-gu, Seoul 137-701, Republic of KoreaDepartment of Hospital Pathology, College of Medicine, The Catholic University of Korea, 222 Banpodaero, Seocho-gu, Seoul 137-701, Republic of KoreaBackground. Most patients with a preoperative diagnosis of thyroid follicular neoplasm (FN) undergo diagnostic surgery to determine whether the nodule is benign or malignant. Point mutations at NRAS codon 61 are the most common mutations observed in FN. However, the clinical significance of NRAS mutation remains unclear. Methods. From 2012 to 2013, 123 consecutive patients undergoing thyroidectomy for FN were evaluated prospectively. Molecular analyses for NRAS codon 61 were performed with pyrosequencing. Results. The overall malignancy rate in FN was 48.8% (60/123). Of 123 FNs, 33 (26.8%) were positive for the NRAS mutation. The sensitivity, specificity, positive predictive value, and negative predictive value of a NRAS mutation-positive FN specimen to predict malignancy were 37%, 83%, 67%, and 58%, respectively. Patients with a NRAS-positive FN had a higher malignancy rate in additional thyroid nodules beyond the FN than patients with a NRAS-negative FN. The overall malignancy rate of patients with a NRAS-positive FN was significantly higher than that of patients with a NRAS-negative FN (79% versus 52%; P = 0.008). Conclusions. Determining NRAS mutation status in FN helps to improve the accuracy of thyroid cancer diagnosis and to predict cancer risk in accompanying thyroid nodules.http://dx.doi.org/10.1155/2014/289834
spellingShingle Ja-Seong Bae
Seung Kyu Choi
Sora Jeon
Yourha Kim
Sohee Lee
Youn Soo Lee
Chan Kwon Jung
Impact of NRAS Mutations on the Diagnosis of Follicular Neoplasm of the Thyroid
International Journal of Endocrinology
title Impact of NRAS Mutations on the Diagnosis of Follicular Neoplasm of the Thyroid
title_full Impact of NRAS Mutations on the Diagnosis of Follicular Neoplasm of the Thyroid
title_fullStr Impact of NRAS Mutations on the Diagnosis of Follicular Neoplasm of the Thyroid
title_full_unstemmed Impact of NRAS Mutations on the Diagnosis of Follicular Neoplasm of the Thyroid
title_short Impact of NRAS Mutations on the Diagnosis of Follicular Neoplasm of the Thyroid
title_sort impact of nras mutations on the diagnosis of follicular neoplasm of the thyroid
url http://dx.doi.org/10.1155/2014/289834
work_keys_str_mv AT jaseongbae impactofnrasmutationsonthediagnosisoffollicularneoplasmofthethyroid
AT seungkyuchoi impactofnrasmutationsonthediagnosisoffollicularneoplasmofthethyroid
AT sorajeon impactofnrasmutationsonthediagnosisoffollicularneoplasmofthethyroid
AT yourhakim impactofnrasmutationsonthediagnosisoffollicularneoplasmofthethyroid
AT soheelee impactofnrasmutationsonthediagnosisoffollicularneoplasmofthethyroid
AT younsoolee impactofnrasmutationsonthediagnosisoffollicularneoplasmofthethyroid
AT chankwonjung impactofnrasmutationsonthediagnosisoffollicularneoplasmofthethyroid